The International Committee For Insurance Medicine

ICLAM was founded in Amsterdam in 1901 at the second World conference of Insurance medicine, but its history started with the first World conference in Brussels in 1899. 

 

 The ICLAM Congresses since 1935 have come the international benchmark for congress aimed at scientific training, interactive discussions and networking on topics related to insurance medicine, risk underwriting, and more recently claim assessment. It has a proud tradition and is well respected for high quality of its faculty and presentations

 

 ICLAM is an independent non-profit organization and has no commercial interests.

ICLAM’s Goals

ICLAM’s aims are to provide an international forum for the latest insights and statistics on prognosis of medical and surgical treatment in the field of life, disability and health insurance.

ICLAM arranges World conferences of Insurance medicine every three years and gives support to new organizations of insurance medicine on all continents.

<strong>Want to learn more about ICLAM?</strong>

Want to learn more about ICLAM?

Visit the ICLAM websites listed in the blue bar above to learn more about the next ICLAM Annual Seminar and Triennial World Conference, ICLAM Profile, and Awards.

<strong>Insurance Medicine links</strong>

Insurance Medicine links

Find links to other organisations dealing with Insurance Medicine, Underwriting and Claims

Membership of ICLAM is free

ICLAM’s Blogs

Whether you’d like to share your knowledge, experiences or the latest news, ICLAM is the right  platform to share it with all those who have interest in field of Insurance Medicine

Please write to us at contact@iclam.org with your blog and we will be happy to share it on this page

  • Biosimilars – a novel aspect of cost containment in Health Insurance With the advent of personalised medicine, it became obvious that in many cases the cost of pharmaceutical therapy presents a serious challenge to health insurers – and often also to the insured individual. For......

  • When we – very in early 2020 –  realized that SARS-CoV-2 is a virus with significant potential to result in a worldwide spread, i.e. it may not be confined to China, where the first cases were reported, the board of ICLAM started to become nervous.......